skip to main content

The Terry Fox Research Institute


The Terry Fox Research Institute (TFRI), named for Canadian icon Terry Fox, is built on Terry's dream to end cancer through research.

Established in 2007, TFRI invests in world-class, collaborative cancer research teams and partnerships. Together with its research and funding partners, TFRI is working to inspire the transformation of cancer research in this country by bringing together leading cancer research and treatment organizations in Canada and empowering them under the framework of the Marathon of Hope Cancer Centres Network and the Digital Health and Discovery Platform. TFRI collaborates with the Terry Fox Foundation and Terry Fox Centre as a member of a trio of Terry Fox organizations created in memory of the Canadian hero and champion of cancer research.

Atlantic Cancer Consortium Pilot for the Marathon of Hope Cancer Centres Network

With a commitment to work together and $3.6 million in new funding from provincial and national partners, doctors and scientists at leading cancer centres, hospitals and research in Nova Scotia, New Brunswick and Newfoundland & Labrador have formed an alliance focused on providing improved cancer outcomes. The group will work together under a joint pilot project over two years with the goal of...

Read More

Determinants of stemness that underlie high risk or relapse disease

There’s an analogy that Dr. John Dick likes to use to describe cancer. For him, cancer is like a weed, with the tumour being the leafy part that sits above ground. The roots, on the other hand, are the cells that initiate and sustain a cancer’s growth. “Like a weed, cancer can only be killed if the root is removed entirely,” says Dr. Dick, a senior scientist at Toronto&rsqu...

Read More

Targeting the Hippo Signaling Network in Cancer

  • Jeff Wrana / Lunenfeld-Tanenbaum Research Institute

In order to grow, cancers must overcome a series of mechanisms that control the normal functioning of our cells. One such mechanism is known as the “Hippo” pathway. “The main job of this pathway is to control tissue size,” explains Dr. Jeff Wrana, a senior investigator at Toronto’s Lunenfeld-Tanenbaum Research Institute (LTRI) at Sinai Health. “When this pathway...

Read More

Access to precision therapies for young people with cancer: From genomic innovation to health system implementation

In recent years, new technologies have enabled researchers to gain a clearer understanding of the genetic mutations that cause cancer in each individual. These discoveries are ushering in a new era in cancer research and care known as precision medicine. Precision medicine has the potential to provide patients with treatment tailored to their individual cancer. But uncertainty about how effective ...

Read More

Measuring and targeting symptom burden among adolescents and young adults with cancer: A population-based study using routinely collected patient reported outcomes

How does cancer affect adolescents and young adults with cancer? What kind of side effects do they experience from treatment and how do these symptoms affect their outcome? These are just some of the questions that Dr. Sumit Gupta, a pediatric oncologist at The Hospital for Sick Children (SickKids) in Toronto, will try to answer thanks to a recently granted Terry Fox New Investigators Award. Dr. G...

Read More

Symptom Burden as a Predictor of Emergency Room Visits and Unplanned Hospitalizations in Patients with Head and Neck Cancer

A Toronto-based surgeon-scientist will use a recently granted Terry Fox New Investigator Award to study how symptoms associated with current therapies affect the lives of patients with head and neck cancers. Dr. Antoine Eskander (Sunnybrook Health Sciences Centre and the Sunnybrook Research Institute) will receive $450,000 over three years from the Terry Fox Research Institute and the Canadian Ins...

Read More

Deciphering recurrence of glioblastoma for precision medicine using multi-omics data integration

A Toronto-based researcher will use integrative machine learning strategies try to turn the tide on a deadly brain cancer thanks to new funding provided by the Terry Fox New Investigator Award. Dr. Jüri Reimand, a computational biologist at the Ontario Institute for Cancer Research, will receive a total of $450,000 from the Terry Fox Research Institute (TFRI) and the Canadian Institutes of He...

Read More

Deciphering the therapy-driven molecular evolution of glioblastoma stem cells

If you were to look inside a tumour, you’d notice that not all its cells are the same. In fact, over the past decade researchers have found that tumours contain several types of cells, each with specific functions and characteristics. Cancer stem cells (CSCs) are one of these cell types. Often referred to as the initiating cells of cancer, studies have shown that CSCs often survive therapeut...

Read More
  • Funding Programs

    The Terry Fox Research Institute functions as the research arm of The Terry Fox Foundation. In this capacity, the Institute invests and manages approximately $27 million in combined funding for discovery and translational research and training for future scientists and clinicians in cancer research.

    Read More
  • Our Research

    We know more about cancer today thanks to the biological, molecular and genomic discoveries, new technologies, tests and treatments made possible with research funding from The Terry Fox Foundation and through the translational work undertaken by TFRI. As a result, we have better ways to detect, diagnose and treat cancer today. This is helping cancer patients to live, to live longer and with a better quality of life.

    Read More
  • Terry Fox and the Terry Fox Foundation

    Terry Fox was born in Winnipeg, Manitoba, and raised in Port Coquitlam, British Columbia, a community near Vancouver on Canada's west coast. An active teenager involved in many sports, Terry was only 18 years old when he was diagnosed with osteogenic sarcoma (bone cancer) and forced to have his right leg amputated 15 centimetres (six inches) above the knee in 1977.

    Read More
  • Digital Health and Discovery Platform

    The Digital Health and Discovery Platform (DHDP) is a pan-Canadian initiative that seeks to improve health outcomes for Canadians by deploying cutting-edge technologies that advance precision medicine.

    Read More
  • Marathon of Hope Cancer Centres

    The Marathon of Hope Cancer Centres Network is a bold vision led by The Terry Fox Research Institute and The Terry Fox Foundation with support from dozens of research and funding partners across Canada.

    Read More
Aimee Zeglinski-Spinney

Teen bone cancer survivor credits Terry Fox research advances for her survival

Read Story
Donna Goudard

“Let’s find something you can test for, and cure ovarian cancers!”

Read Story
Yves Tellier

Immunotherapy gives melanoma cancer survivor a second chance at life

Read Story
Luana Locke

Patient participates in study to help stop rare but deadly hereditary cancer before it strikes

Read Story
Debbie Duclos

Study participant benefits from “personalized chemotherapy” for breast cancer patients

Read Story


  • 2019/20 Facts

    • 26.6 Million Dollars for Cancer Research and Training
      Million Dollars for Cancer Research and Training
    • 47 currently funded projects for team science and research
      Funded Projects for team science and research
    • 98 Partners in Funding and Research
      Partners in Funding and Research